Gilead Sciences (GILD) FY2022 results: revenue $27.3 billion, down 0.1% on the year
Gilead Sciences, Inc. (GILD) reported revenue of $27.3 billion for fiscal 2022, the year ended 31 December 2022, down 0.1% on the year before. Net income was $4.6 billion, down 26.2%, and diluted earnings per share $3.64. The figures are the company's own, from the 10-K it filed with the SEC on 22 February 2023.
Revenue
$27.3 billion
-0.1% on the year
FY2015FY2022
Operating margin
26.9%
36.3% a year earlier
FY2015FY2022
Net income
$4.6 billion
-26.2% on the year
FY2015FY2022
Diluted EPS
$3.64
-26.2% on the year
FY2015FY2022
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Operating cash flow
9,072
11,384
8,168
-20.3%
Capital expenditure
728
579
650
+25.7%
Free cash flow
8,344
10,805
7,518
-22.8%
Free cash flow margin
30.6%
39.6%
30.5%
Cash from investing
-2,466
-3,131
-14,615
Cash from financing
-6,469
-8,877
770
Depreciation and amortisation
2,123
2,029
1,488
+4.6%
Share-based compensation
637
635
643
+0.3%
Buybacks
1,396
546
1,583
+155.7%
Dividends paid
3,709
3,605
3,449
+2.9%
Dividend per share
$2.92
$2.84
$2.72
+2.8%
Diluted shares, weighted
1,262m
1,262m
1,263m
0.0%
Shares outstanding at period end
1,247m
1,254m
1,254m
-0.6%
Balance sheet
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Shareholders' equity
21,240
21,069
18,202
+0.8%
Non-controlling interest
-31.0
-5.0
19.0
Debt
25,229
26,695
31,402
-5.5%
Operating lease liabilities
467
489
608
-4.5%
Other liabilities
16,266
19,704
18,176
-17.4%
Total liabilities and equity
63,171
67,952
68,407
-7.0%
Fixed assets
5,475
5,121
4,967
+6.9%
Goodwill
8,314
8,332
8,108
-0.2%
Intangible assets
28,894
33,455
33,126
-13.6%
Investments
2,218
2,491
1,913
-11.0%
Cash and equivalents
5,412
5,338
5,997
+1.4%
Receivables
4,777
4,493
4,892
+6.3%
Inventory
1,507
1,618
1,683
-6.9%
Other assets
6,574
7,104
7,721
-7.5%
Total assets
63,171
67,952
68,407
-7.0%
10-K for the year ended 31 December 2022, filed 22 February 2023: the filing.